Grants for Independent school districts - Federal

The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC), invites grant applications for Training Project Grants (TPGs) that are focused on occupational safety and health training. NIOSH is mandated to provide an adequate supply of qualified personnel to carry out the purposes of the Occupational Safety and Health Act, and the TPGs are one of the principal means for meeting this mandate. The majority of TPGs are in academic institutions that provide high quality training in the core occupational safety and health disciplines of industrial hygiene (IH), occupational health nursing (OHN), occupational medicine residency (OMR), occupational safety (OS), as well as allied disciplines. NIOSH also funds non-academic programs to meet specific training needs of targeted populations including firefighters, commercial fishermen and occupational health and safety interns.

This funding opportunity supports nonprofit organizations, tribal governments, and educational institutions in engaging underserved youth in outdoor activities, conservation efforts, and career exploration within national parks and public lands.

Ryan White HIV/AIDS Program (RWHAP) Data Integration, Systems, and Quality Technical Assistance (DISQ) is a national training and technical assistance (T/TA) program to support RWHAP recipients and subrecipients. It funds activities to increase access to high-quality HIV care and support services for low-income people with HIV in the United States. The DISQ program develops and disseminates T/TA to help RWHAP recipients and subrecipients develop and implement data collection activities related to HIV care. This program will improve RWHAP recipients and subrecipients capacity to meet data-related program requirements and help them use data to make their programs more efficient and effective. We will award one cooperative agreement to a technical assistance provider. This provider will be responsible for on-site and virtual T/TA to RWHAP recipients and subrecipients.

The Supporting Fetal Alcohol Spectrum Disorders (FASD) Screening and Intervention program helps reduce alcohol use during pregnancy and improves outcomes for children with FASD nationwide, especially in communities where theres a high rate of binge drinking during pregnancy. The program focuses on educating Primary Care Providers (PCPs) and increasing the use of screening, intervention, and referral processes for high-risk pregnancies. The programs goals include increasing PCPs knowledge of the risks of drinking alcohol during pregnancy as well as promoting recommended screenings, interventions, and referral approaches. In addition, PCPs who provide health care to children and adolescents will develop skills to identify and manage FASD, with a particular emphasis on fostering effective communication with families. Through recruitment, education, and technical assistance, the program aims to make lasting positive changes. Engaging a minimum of 80 practices over 5 years, the Supporting FASD Screening and Intervention program strives for widespread impact, particularly in communities that have high rates of binge drinking during pregnancy, including rural areas and medically underserved communities.

This funding opportunity is designed to support researchers investigating the connections between HIV/AIDS and various health issues related to diabetes, digestive, kidney, and metabolic diseases, particularly focusing on the complications and social factors affecting people living with HIV.

The "Engineering Durable HIV Vaccine Responses (ENDURE)" grant aims to fund research that explores the factors influencing the longevity of vaccine responses, with a focus on HIV, in order to improve vaccine design and development, and to devise better methods for measuring long-term immune responses.

This Funding Opportunity Announcement (FOA) encourages pilot and preliminary research in preparation for larger-scale services research effectiveness trials. Relevant trials may test a wide range of approaches, including interventions, practices, and policies designed to optimize access to, and the quality, effectiveness, affordability and utilization of drug, tobacco, or alcohol use disorder treatments and related services, as well as services for comorbid medical and mental disorder conditions. Relevant approaches may include both those that are novel, and those that are commonly used in practice but lack an evidence base. This FOA provides resources for assessing the feasibility, acceptability, and utility of these approaches, in addition to usual trial preparation activities.

This funding opportunity supports research projects that utilize existing cancer epidemiology cohort data to investigate important questions about cancer prevention, treatment, and survivorship, particularly for underserved populations and rare cancers.

The National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for the TrialNet Coordinating Center (TNCC). The TrialNet network identifies people with type 1 diabetes (T1D) at stages before and after onset of clinical symptoms and enrolls them in trials and studies aimed at prevention of progression to clinical disease and preservation of insulin production. The TNCC participates in ongoing studies and intervention trials as well as the design and conduct of new studies and intervention trials. The TNCC will: (1) support a wide range of research projects in varying stages of development, implementation and completion, and (2) provide data and sample management, including standardized acquisition, quality control, dissemination and public accessibility. The TNCC will be responsible for network administration and operations, including the evaluation, selection, and funding (through subcontracts) of Clinical Centers and central support units (such as laboratories) necessary for the conduct of TrialNets clinical studies. The TNCC PD/PI will be a voting member of the TrialNet Executive and Steering Committees, contributing to network leadership. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. This NOFO will utilize the U01 activity code. Details of the planned NOFO are provided below.

Not available

This funding opportunity provides up to $1 million to a wide range of organizations to develop a centralized resource for exploring and analyzing single-cell genomics data from the human brain, enhancing research on brain health and disease.

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mechanisms by which bariatric surgery impacts cancer risk, and seeks to draw in talented scientists who study bariatric surgery to investigate its effects on cancer, rather than shorter term outcomes such as weight loss and diabetes. The goal of this FOA is to support proof of concept studies for feasibility and exploratory development. Feasibility must not have already been developed in the literature or with preliminary data. While unpublished data are not permitted, references and data from widely available preprints that have a Digital Object Identifier (DOI) are acceptable. Investigators who have generated unpublished preliminary data should submit a proposal to companion R01.

This funding opportunity supports researchers with a strong background in promoting diversity, equity, inclusion, and accessibility in biomedical fields, enabling them to conduct scientific research while advancing DEIA initiatives within the academic and scientific communities.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated efficacy clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests of the NINDS and may evaluate drugs, biologics, and devices, as well as surgical, behavioral and rehabilitation therapies. Information about the mission and research interests of the NINDS can be found at the NINDS website (http://www.ninds.nih.gov/)

This grant provides financial support for early-career researchers from diverse backgrounds to establish independent cancer research careers, particularly those planning to lead clinical trials.

This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects which translate basic research findings into clinical tools for better human health. The scope of this FOA includes a range of activities to encourage translation of basic research findings which will impact the diagnosis, treatment and prevention of communication disorders. Connection to the clinical condition must be clearly established and the outcomes of the grant must have practical clinical impact.

The grant titled "The NINDS Human Cell and Data Repository" aims to support the maintenance and development of a repository for fibroblast and induced pluripotent stem cell lines, which will be distributed to researchers for advancing research in neurological disorders.

This grant provides funding to early career researchers proposing innovative studies on the genetics or epigenetics of substance use disorders, aiming to foster new insights and advancements in addiction research.

This funding opportunity announcement (FOA) invites applications for the Clinical and Translational Science Award (CTSA) Program hubs that will be part of a national, collaborative consortium focused on bringing more treatments to more patients more quickly through advancing clinical and translational science (CTS) by (1) developing, demonstrating, and disseminating scientific and operational innovations that improve the efficiency and effectiveness of clinical translation from identification to first-in-human studies to medical practice implementation to community health dissemination; (2) promoting partnerships and collaborations to facilitate and accelerate translational research projects locally, regionally, and nationally; (3) creating, providing, and disseminating innovative research programs and partnerships across institutions and communities to address health disparities and deliver the benefits of translational science to all; (4) creating and implementing scientific and operational innovations that increase the quality, safety, efficiency, effectiveness, and informativeness of clinical research; (5) providing a national resource for the rapid response to urgent public health needs; and (6) creating, providing, and disseminating CTS training for clinical research professionals of all disciplines on the research team. Along with this solicitation for the UM1 CTSA hub application, NCATS has published a separate, companion FOA that solicits applications for a required K12 Clinical Scientist Institutional Career Development Program Award (PAR-TR-22-career); both a UM1 hub application and the required K12 application must be submitted. If there is no companion K12 application submitted, the UM1 hub application will not be reviewed. However, if the UM1 application is funded and the companion K12 application is not funded, a resubmitted K12 application will be accepted. Additional companion FOAs solicit applications for optional training, career, and research ed

This funding opportunity provides financial support to various organizations, including governments and nonprofits, to raise awareness and improve understanding of Alpha-gal Syndrome across the United States, particularly in underserved areas.